Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, et al.
Journal of Affective Disorders (2012) Vol. 141, Iss. 2-3, pp. 308-314
Closed Access | Times Cited: 309

Showing 1-25 of 309 citing articles:

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
Ole Köhler‐Forsberg, Michael E. Benros, Merete Nordentoft, et al.
JAMA Psychiatry (2014) Vol. 71, Iss. 12, pp. 1381-1381
Open Access | Times Cited: 821
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Amirhossein Modabbernia, Shervin Taslimi, Elisa Brietzke, et al.
Biological Psychiatry (2013) Vol. 74, Iss. 1, pp. 15-25
Closed Access | Times Cited: 554
Inflamed moods: A review of the interactions between inflammation and mood disorders
Joshua D. Rosenblat, S. Danielle, Rodrigo B. Mansur, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2014) Vol. 53, pp. 23-34
Closed Access | Times Cited: 553
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Müller
Schizophrenia Bulletin (2018) Vol. 44, Iss. 5, pp. 973-982
Open Access | Times Cited: 520
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Ole Köhler‐Forsberg, Jesper Krogh, Ole Mors, et al.
Current Neuropharmacology (2016) Vol. 14, Iss. 7, pp. 732-742
Open Access | Times Cited: 453
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Krithika Srikanthan, Andrew Feyh, Haresh Visweshwar, et al.
International Journal of Medical Sciences (2015) Vol. 13, Iss. 1, pp. 25-38
Open Access | Times Cited: 396
Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
Roger S. McIntyre, Marie‐Josée Filteau, Lawrence Martin, et al.
Journal of Affective Disorders (2013) Vol. 156, pp. 1-7
Closed Access | Times Cited: 385
NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder
Elísabet Alcocer‐Gómez, Manuel de Miguel, N. Casas Barquero, et al.
Brain Behavior and Immunity (2013) Vol. 36, pp. 111-117
Closed Access | Times Cited: 383
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
Michael Berk, Olivia Dean, Hemmo A. Drexhage, et al.
BMC Medicine (2013) Vol. 11, Iss. 1
Open Access | Times Cited: 382
Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
Ole Köhler‐Forsberg, Cecilie N. Lydholm, Carsten Hjorthøj, et al.
Acta Psychiatrica Scandinavica (2019) Vol. 139, Iss. 5, pp. 404-419
Closed Access | Times Cited: 337
Role of Interleukin-6 in Depressive Disorder
Emily Yi-Chih Ting, Albert C. Yang, Shih‐Jen Tsai
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2194-2194
Open Access | Times Cited: 275
The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression
Piotr Czarny, Paulina Wigner, Piotr Gałecki, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 80, pp. 309-321
Closed Access | Times Cited: 263
Neuroinflammation in Bipolar Depression
Francesco Benedetti, Veronica Aggio, Maria Luisa Pratesi, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 238
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy
Paula Kopschina Feltes, Janine Doorduin, Hans Klein, et al.
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1149-1165
Open Access | Times Cited: 235
Dysregulated relationship of inflammation and oxidative stress in major depression
Blake Rawdin, Synthia H. Mellon, F.S. Dhabhar, et al.
Brain Behavior and Immunity (2012) Vol. 31, pp. 143-152
Open Access | Times Cited: 232
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Lulu Cui, Shu Li, Siman Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 219
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Elena Dale, Benny Bang‐Andersen, Connie Sanchéz
Biochemical Pharmacology (2015) Vol. 95, Iss. 2, pp. 81-97
Open Access | Times Cited: 214
Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders
Sinead M. Gibney, Hemmo A. Drexhage
Journal of Neuroimmune Pharmacology (2013) Vol. 8, Iss. 4, pp. 900-920
Closed Access | Times Cited: 212
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 200
Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
Magdalena Więdłocha, Piotr Marcinowicz, Renata Krupa, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 80, pp. 217-226
Closed Access | Times Cited: 198
Gut microbiota–brain axis in depression: The role of neuroinflammation
Anelise S. Carlessi, Laura A. Borba, Alexandra I. Zugno, et al.
European Journal of Neuroscience (2019) Vol. 53, Iss. 1, pp. 222-235
Open Access | Times Cited: 188
Neuroimmune signaling in alcohol use disorder
Emma K. Erickson, Emily K. Grantham, Anna S. Warden, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 177, pp. 34-60
Open Access | Times Cited: 185
Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
Maria Antonietta Nettis, Giulia Lombardo, Caitlin Hastings, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 5, pp. 939-948
Open Access | Times Cited: 179
Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials
Shuang Bai, Wenliang Guo, Yangyang Feng, et al.
Journal of Neurology Neurosurgery & Psychiatry (2019) Vol. 91, Iss. 1, pp. 21-32
Closed Access | Times Cited: 178
The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders
Yang Jin, Li Sun, Wei Yang, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 168
Page 1 - Next Page

Scroll to top